Citoxlab acquires Xenometrics
An American CRO specialized in preclinical assessment of new drug candidates
Citoxlab Group, a leading player among non-clinical CROs, announces the acquisition of Xenometrics, an American CRO specialized in the non-clinical assessment of new drug candidates.
CNS Safety Pharmacology
Discover EEG as a powerful neurological readout with established translational applications:
Continuous video-EEG, electro-oculogram, electromyogram, telemetry in conscious models, seizure liability, etc.
Dermal drug and skincare products
25-years of dedicated experience
From preclinical to clinical phase III development: Wound healing efficacy models, early screening, skin sensitization, 3D skin models, etc.
Prepare your regulatory submissions
Discover our customized packages and benefit from our unique expertise in nose-only and oro-nasal exposure.
Discover our growing portfolio of more than 200 biomarkers
Explore our translational science expertise through highly relevant preclinical and clinical biomarkers platforms.
Find out more: ELISA, ELISPOT, Functional assays, Flow cytometry and activation testing, Multiplex analysis, qPCR, genomics, etc.
DART: New non-rodent models
Work with our science-driven teams
Multispecies early to late developmental assessment /
ePPND studies in rabbits for vaccines and biotech-derived products /
EFD studies in non-human primates.